Zhang Y, Shen Y, Wu J, Zhang J, Cao C, Mo J
Onco Targets Ther. 2024; 17:755-763.
PMID: 39282132
PMC: 11402363.
DOI: 10.2147/OTT.S468352.
Frille A, Boeschen M, Wirtz H, Stiller M, Blaker H, von Laffert M
Front Oncol. 2024; 14:1357583.
PMID: 39156705
PMC: 11327858.
DOI: 10.3389/fonc.2024.1357583.
Culliford R, Lawrence S, Mills C, Tippu Z, Chubb D, Cornish A
Nat Commun. 2024; 15(1):5935.
PMID: 39009593
PMC: 11250826.
DOI: 10.1038/s41467-024-49692-1.
Johnson G, Gould S, Sanchez-Rivera F
Biochem Soc Trans. 2024; 52(2):803-819.
PMID: 38629716
PMC: 11088927.
DOI: 10.1042/BST20230984.
Houlston R, Culliford R, Lawrence S, Mills C, Tippu Z, Chubb D
Res Sq. 2023; .
PMID: 38106039
PMC: 10723546.
DOI: 10.21203/rs.3.rs-3675752/v1.
Case report and literature review: exploration of molecular therapeutic targets in recurrent malignant meningioma through comprehensive genetic analysis with Todai OncoPanel.
Ohara K, Miyawaki S, Nakatomi H, Okano A, Teranishi Y, Shinya Y
Front Neurol. 2023; 14:1270046.
PMID: 38073632
PMC: 10702344.
DOI: 10.3389/fneur.2023.1270046.
TERT Promoter Mutations Frequency Across Race, Sex, and Cancer Type.
El Zarif T, Machaalani M, Nawfal R, Nassar A, Xie W, Choueiri T
Oncologist. 2023; 29(1):8-14.
PMID: 37462445
PMC: 10769781.
DOI: 10.1093/oncolo/oyad208.
Homogenous TP53mut-associated tumor biology across mutation and cancer types revealed by transcriptome analysis.
Romanovsky E, Kluck K, Ourailidis I, Menzel M, Beck S, Ball M
Cell Death Discov. 2023; 9(1):126.
PMID: 37059713
PMC: 10104808.
DOI: 10.1038/s41420-023-01413-1.
Combination of Tumor Mutational Burden and Specific Gene Mutations Stratifies Outcome to Immunotherapy Across Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma.
Peng Y, Wang R, Liu Q, Xu X, Wei W, Huang X
Front Genet. 2021; 12:756506.
PMID: 34868231
PMC: 8637214.
DOI: 10.3389/fgene.2021.756506.
Immune Cell Infiltration Landscape of Ovarian Cancer to Identify Prognosis and Immunotherapy-Related Genes to Aid Immunotherapy.
Li X, Liang W, Zhao H, Jin Z, Shi G, Xie W
Front Cell Dev Biol. 2021; 9:749157.
PMID: 34805159
PMC: 8595115.
DOI: 10.3389/fcell.2021.749157.
A Rare BRAF Fusion in Advanced Rectal Cancer Treated with Anti-Epidermal Growth Factor Receptor Therapy.
Hasegawa H, Miyo M, Mori K, Mano M, Ishida H, Mita E
Case Rep Oncol. 2021; 14(2):938-943.
PMID: 34267639
PMC: 8261262.
DOI: 10.1159/000517007.
Enhancing chemotherapy response through augmented synthetic lethality by co-targeting nucleotide excision repair and cell-cycle checkpoints.
Kong Y, Dreaden E, Morandell S, Zhou W, Dhara S, Sriram G
Nat Commun. 2020; 11(1):4124.
PMID: 32807787
PMC: 7431578.
DOI: 10.1038/s41467-020-17958-z.
E-cadherin immunohistochemical expression in invasive lobular carcinoma of the breast: correlation with morphology and CDH1 somatic alterations.
Grabenstetter A, Mohanty A, Rana S, Zehir A, Brannon A, DAlfonso T
Hum Pathol. 2020; 102:44-53.
PMID: 32599083
PMC: 7484442.
DOI: 10.1016/j.humpath.2020.06.002.
The mutREAD method detects mutational signatures from low quantities of cancer DNA.
Perner J, Abbas S, Nowicki-Osuch K, Devonshire G, Eldridge M, Tavare S
Nat Commun. 2020; 11(1):3166.
PMID: 32576827
PMC: 7311535.
DOI: 10.1038/s41467-020-16974-3.
Mammalian SWI/SNF Complex Genomic Alterations and Immune Checkpoint Blockade in Solid Tumors.
Abou Alaiwi S, Nassar A, Xie W, Bakouny Z, Berchuck J, Braun D
Cancer Immunol Res. 2020; 8(8):1075-1084.
PMID: 32321774
PMC: 7415546.
DOI: 10.1158/2326-6066.CIR-19-0866.
Mining TCGA database for tumor mutation burden and their clinical significance in bladder cancer.
Lv J, Zhu Y, Ji A, Zhang Q, Liao G
Biosci Rep. 2020; 40(4).
PMID: 32239176
PMC: 7178217.
DOI: 10.1042/BSR20194337.
Cascading After Peridiagnostic Cancer Genetic Testing: An Alternative to Population-Based Screening.
Offit K, Tkachuk K, Stadler Z, Walsh M, Diaz-Zabala H, Levin J
J Clin Oncol. 2020; 38(13):1398-1408.
PMID: 31922925
PMC: 7193752.
DOI: 10.1200/JCO.19.02010.
5-Fluorouracil treatment induces characteristic T>G mutations in human cancer.
Christensen S, van der Roest B, Besselink N, Janssen R, Boymans S, Martens J
Nat Commun. 2019; 10(1):4571.
PMID: 31594944
PMC: 6783534.
DOI: 10.1038/s41467-019-12594-8.
Pan-Trk immunohistochemistry is a sensitive and specific ancillary tool for diagnosing secretory carcinoma of the salivary gland and detecting ETV6-NTRK3 fusion.
Xu B, Haroon Al Rasheed M, Antonescu C, Alex D, Frosina D, Ghossein R
Histopathology. 2019; 76(3):375-382.
PMID: 31448442
PMC: 6994356.
DOI: 10.1111/his.13981.
Targeted deep sequencing from multiple sources demonstrates increased NOTCH1 alterations in lung cancer patient plasma.
Liao Y, Ma Z, Zhang Y, Li D, Lv D, Chen Z
Cancer Med. 2019; 8(12):5673-5686.
PMID: 31369215
PMC: 6745866.
DOI: 10.1002/cam4.2458.
